TNFSF10 and head and neck squamous cell carcinoma: A recent study suggests that TRAIL can exert enhanced cytotoxic activity in cells arrested in G1 or G2 phase.50 Here, bortezomib alone induced clear G2/M arrest in all HPV+ and HPV− HNSCC cell lines, which might contribute to their increased sensitivity to TRAIL.